Kalvista Pharmaceuticals Inc (KALV.OQ)
KALV.OQ on NASDAQ Stock Exchange Global Market
25.50USD
18 Apr 2019
25.50USD
18 Apr 2019
Change (% chg)
$0.11 (+0.43%)
$0.11 (+0.43%)
Prev Close
$25.39
$25.39
Open
$25.29
$25.29
Day's High
$25.84
$25.84
Day's Low
$24.67
$24.67
Volume
14,169
14,169
Avg. Vol
24,574
24,574
52-wk High
$34.65
$34.65
52-wk Low
$7.74
$7.74
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Jan '19 | 3.89 | -0.230 |
| Oct | 5.59 | -0.219 | |
| Jul | 3.72 | -0.466 | |
| FY 2018 | Apr '18 | 4.84 | -0.061 |
| Jan '18 | 2.33 | -0.485 | |
| Oct | 1.13 | -0.498 | |
| Jul | 0.10 | -0.507 | |
| FY 2017 | Apr '17 | 0.11 | -0.440 |
| Jan '17 | 0.25 | -0.998 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jan-19 | 5 | 4.25 | 5.40 | 3.00 | -- |
| Quarter Ending Apr-19 | 4 | 4.33 | 5.03 | 4.00 | -- |
| Year Ending Apr-19 | 4 | 17.13 | 17.40 | 16.62 | 14.40 |
| Year Ending Apr-20 | 5 | 33.44 | 58.50 | 10.00 | 28.80 |
| Earnings (per share) | |||||
| Quarter Ending Jan-19 | 5 | -0.45 | -0.23 | -0.62 | -- |
| Quarter Ending Apr-19 | 4 | -0.35 | -0.31 | -0.42 | -- |
| Year Ending Apr-19 | 4 | -1.17 | -1.07 | -1.29 | -1.59 |
| Year Ending Apr-20 | 5 | -1.61 | -0.02 | -4.21 | -0.54 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 29.30 | 32.55 | |
| P/E High - Last 5 Yrs. | -- | 43.17 | 48.10 | |
| P/E Low - Last 5 Yrs. | -- | 22.71 | 23.42 | |
| Beta | -- | 0.86 | 0.87 | |
| Price to Sales (TTM) | 151.44 | 6.59 | 8.39 | |
| Price to Book (MRQ) | 2.63 | 5.12 | 5.27 | |
| Price to Tangible Book (MRQ) | 2.63 | 5.84 | 6.74 | |
| Price to Cash Flow (TTM) | -- | 23.07 | 24.13 | |
| % Owned Institutions | 80.82 | 0.87 | 1.65 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.43 | 1.35 | |
| Dividend Yield - 5 Year Avg | -- | 1.45 | 1.37 | |
| Dividend 5 Year Growth Rate | -- | 3.99 | 4.70 | |
| Payout Ratio(TTM) | -- | 42.19 | 39.61 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 1,271.43 | 5.43 | 13.46 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 1,503.45 | 6.61 | 8.04 | |
| Sales - 5 Yr. Growth Rate | -- | 10.48 | 10.85 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 87.02 | 45.67 | 47.73 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 75.80 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 9.90 | 10.46 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 15.26 | 14.68 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.07 | 2.18 |
| Current Ratio (MRQ) | 7.87 | 2.87 | 2.98 |
| LT Debt to Equity (MRQ) | 0.80 | 8.87 | 11.32 |
| Total Debt to Equity (MRQ) | 1.55 | 12.86 | 16.01 |
| Interest Coverage (TTM) | -29.72 | 32.48 | 28.44 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 52.10 | 52.41 | |
| Gross Margin - 5 Yr. Avg. | -- | 49.66 | 50.39 | |
| EBITD Margin (TTM) | -4,520.00 | -- | -- | |
| EBITD - 5 Yr. Avg | -- | 17.26 | 12.41 | |
| Operating Margin (TTM) | -4,529.25 | 13.53 | 5.77 | |
| Operating Margin - 5 Yr. Avg. | -- | 13.69 | 8.01 | |
| Pre-Tax Margin (TTM) | -4,120.21 | 11.88 | 4.79 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | 14.09 | 8.29 | |
| Net Profit Margin (TTM) | -4,120.21 | 8.79 | 1.52 | |
| Net Profit Margin - 5 Yr. Avg. | -- | 10.58 | 4.70 | |
| Effective Tax Rate (TTM) | -- | 22.12 | 22.13 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 22.26 | 22.58 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 928,597,997 | 820,413,093 | |
| Net Income/Employee (TTM) | -- | 105,162,136 | 92,866,243 | |
| Receivable Turnover (TTM) | -- | 5.84 | 5.82 | |
| Inventory Turnover (TTM) | -- | 2.57 | 3.41 | |
| Asset Turnover (TTM) | 0.01 | 0.93 | 0.90 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -55.70 | 10.98 | 10.60 | |
| Return on Assets - 5 Yr. Avg. | -- | 12.41 | 11.78 | |
| Return on Investment (TTM) | -60.80 | 14.23 | 13.83 | |
| Return on Investment - 5 Yr. Avg. | -- | 16.18 | 15.32 | |
| Return on Equity (TTM) | -61.05 | 15.46 | 15.25 | |
| Return on Equity - 5 Yr. Avg. | -- | 17.07 | 16.41 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -- | -- |
| EPS (TTM) % | -- | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Kalvista Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -12.01 | -15.05 | 10 | 29 |
| 13 Week | 1.40 | -3.54 | 60 | 42 |
| 26 Week | -3.33 | -10.68 | 48 | 44 |
| 52 Week | -4.10 | -18.72 | 44 | 11 |
| YTD | 2.55 | -9.94 | 47 | 38 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 75.77% |
| # of Holders: | 81 |
| Total Shares Held: | 13,068,517 |
| 3 Mo. Net Change: | -566,824 |
| # New Positions: | 6 |
| # Closed Positions: | 0 |
| # Increased Positions: | 8 |
| # Reduced Positions: | 5 |
| # Net Buyers: | 3 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.